On September 21, 2023, the Consumer Financial Protection Bureau (CFPB) initiated a rulemaking process with the concern of medical payment products at its core. The process was launched after a short time frame to review comments received from a request for information. This move, as outlined in a press release from the regulatory body, is particularly centered around an effort to elliminate medical bills from Americans’ credit reports. Nevertheless, the purview of the proposed rulemaking isn’t just confined to that, it incorporates alterations to pivotal definitions and processes under the Fair Credit Reporting Act (FCRA) as well.
Details about specific implications of the new definitions, the interpretive changes, and the adjustments to the processes are currently sparse. Given the early rulemaking stage, the likely regulatory modifications under the FCRA remain speculative. However, some potential modifications could include redefining what constitutes a credibility report, reinterpreting the responsibilities of creditors, and changing how information is disclosed. These potential modifications could influence the rules and procedures governing how companies share consumers’ credit information, the expectations held of them when they do, the liability they bear, and importantly, how consumer’s financial health is evaluated.
As lawyer is of utmost import to stay informed. Law firms, financial institutions, and any other entities regulated by the FCRA must watch these potential changes closely. These could directly influence compliance policies, creating alteration needs in response to the new rules or adjusting to the revised meanings and processes.
For in-depth analysis of the original rulemaking announcement from the CFPB, go to Ballard Spahr LLP.